Dr. Sally S. Ball, MD

Dr. Ball practices at Willis Knighton Pierremont in Shreveport, Louisiana.

Dr. Ball's NPI, 1568441251, was assigned on January 11, 2006. Dr. Ball graduated from Louisiana State University School of Medicine in 1995. Dr. Ball holds Louisiana license 022535.

Dr. Ball's primary practice is Willis Knighton Pierremont, at 8001 Youree Dr, Shreveport, LA 71115 in Caddo Parish. The practice phone is (318) 212-3456.

Dr. Ball's primary practice is Willis Knighton Pierremont in Shreveport, Louisiana. Dr. Ball is also affiliated with Willis Knighton North. The medical group on file is Internal Medicine Associates. Dmand AI also links Dr. Ball to 1 more hospital, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ball practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ball's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ball is licensed in Louisiana.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, adjustment disease, alcohol use disorders, aneurysm and ankle or foot injury among the conditions Dr. Ball treats.

CMS data shows 2,559 Medicare services from Dr. Ball across 21 procedure codes in 2024, for 432 Medicare patients. Medicare paid $146,846 for them. Every service was in an office.

CMS counts 432 Medicare patients who saw Dr. Ball in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ball's median patient age at 72, with 74% women.

In 2024, Dr. Ball wrote 8,898 Medicare Part D claims for 626 patients. 88% of them were for generic drugs. CMS names the drug for 8,118 of them, across 125 drugs with 11 or more claims each, at $550,905 in total drug cost. In 2023, CMS named 7,358 claims across 118 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Ball for performance year 2024, reported through an alternative payment model (APM). Dr. Ball accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Ball, published from 2021 to 2023. Dr. Ball has published most often in Australas J Dermatol.

CMS Open Payments shows 461 general payments to Dr. Ball from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Daiichi Sankyo Inc. paid the most, $2,027.

Dmand AI lists 1 award for Dr. Ball, most recently CMS Stage 1 EHR in 2013.

Dr. Ball graduated from Louisiana State University School of Medicine in 1995.

Dr. Ball is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.